Changing the FDA biosimilar interchangeability standards is a necessary but likely insufficient step to improve biosimilar competition in the US. In 2009, Congress created a regulatory pathway for ...

The US Food and Drug Administration is easing some requirements for drugmakers developing copycat versions of costly biologic ...

Pregnant women who take biologic medication for rheumatoid arthritis are not running the risk of their infant developing serious/opportunistic infections, according to research presented at the 2017 ...

The Food and Drug Administration said it will take steps to speed up the process of developing generic versions of complex biological drugs, in a bid to increase cheaper competition for expensive ...

People with psoriasis prescribed bimekizumab have no greater risk for major depressive disorder or suicidal ideation than ...

If you have moderate to severe ulcerative colitis (UC) and haven’t found enough relief from traditional medications, your doctor may talk to you about biologics. These newer drugs, which include ...

Tumour necrosis factor (TNF) inhibitors are more likely discontinued due to ineffectiveness in patients aged 16-24 years than in those aged 45-54 years. However, patients aged ≥ 75 years have an ...

Biologic drugs have improved how doctors treat serious illnesses. Instead of being made from chemicals, biologics are made from organic materials and grown in living cells. Biologic drugs are used ...

Biocon Biologics is among the leading global suppliers of biosimilar insulins and has been expanding its portfolio ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...